HETEROARYL DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT
The present invention relates to an isoxazolidin-2-yl-substituted heteroaryl derivative and a pharmaceutical composition for cancer prevention or treatment, comprising the compound as an active ingredient. The compound exhibits high inhibitory activity against the wild type or mutants of at least on...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | JUNG, Hongryul YOO, Jihye LEE, Younho SHIM, Inseob KIM, Namdoo HWANG, Seonah SON, Jungbeom DO, Woomi KIM, Sunghwan LEE, Hwa |
description | The present invention relates to an isoxazolidin-2-yl-substituted heteroaryl derivative and a pharmaceutical composition for cancer prevention or treatment, comprising the compound as an active ingredient. The compound exhibits high inhibitory activity against the wild type or mutants of at least one of ErbB2 and ErbB4 and thus can be useful for treating cancers in which ErbB2 and ErbB4 are expressed. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2024262815A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2024262815A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2024262815A13</originalsourceid><addsrcrecordid>eNqNjE0LwjAQRHvxIOp_WPCqYOMHXpdkawImKZu04KkUiSfRQvX_W0XvnmaY95hx9tQUiT3y6QiK2NQYTU0LsBS1V1B4hpKpRDbuAAHtgNApKDWyRUlVNBKPIL0tfTDRePfpbMLPBwyA8n0Kw8SkDLk4zUaX9tqn2Tcn2bygKPUydfcm9V17Trf0aKogVmIjdmKfbzFf_2e9AOO4OjQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>HETEROARYL DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT</title><source>esp@cenet</source><creator>JUNG, Hongryul ; YOO, Jihye ; LEE, Younho ; SHIM, Inseob ; KIM, Namdoo ; HWANG, Seonah ; SON, Jungbeom ; DO, Woomi ; KIM, Sunghwan ; LEE, Hwa</creator><creatorcontrib>JUNG, Hongryul ; YOO, Jihye ; LEE, Younho ; SHIM, Inseob ; KIM, Namdoo ; HWANG, Seonah ; SON, Jungbeom ; DO, Woomi ; KIM, Sunghwan ; LEE, Hwa</creatorcontrib><description>The present invention relates to an isoxazolidin-2-yl-substituted heteroaryl derivative and a pharmaceutical composition for cancer prevention or treatment, comprising the compound as an active ingredient. The compound exhibits high inhibitory activity against the wild type or mutants of at least one of ErbB2 and ErbB4 and thus can be useful for treating cancers in which ErbB2 and ErbB4 are expressed.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240808&DB=EPODOC&CC=US&NR=2024262815A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25569,76552</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240808&DB=EPODOC&CC=US&NR=2024262815A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>JUNG, Hongryul</creatorcontrib><creatorcontrib>YOO, Jihye</creatorcontrib><creatorcontrib>LEE, Younho</creatorcontrib><creatorcontrib>SHIM, Inseob</creatorcontrib><creatorcontrib>KIM, Namdoo</creatorcontrib><creatorcontrib>HWANG, Seonah</creatorcontrib><creatorcontrib>SON, Jungbeom</creatorcontrib><creatorcontrib>DO, Woomi</creatorcontrib><creatorcontrib>KIM, Sunghwan</creatorcontrib><creatorcontrib>LEE, Hwa</creatorcontrib><title>HETEROARYL DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT</title><description>The present invention relates to an isoxazolidin-2-yl-substituted heteroaryl derivative and a pharmaceutical composition for cancer prevention or treatment, comprising the compound as an active ingredient. The compound exhibits high inhibitory activity against the wild type or mutants of at least one of ErbB2 and ErbB4 and thus can be useful for treating cancers in which ErbB2 and ErbB4 are expressed.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjE0LwjAQRHvxIOp_WPCqYOMHXpdkawImKZu04KkUiSfRQvX_W0XvnmaY95hx9tQUiT3y6QiK2NQYTU0LsBS1V1B4hpKpRDbuAAHtgNApKDWyRUlVNBKPIL0tfTDRePfpbMLPBwyA8n0Kw8SkDLk4zUaX9tqn2Tcn2bygKPUydfcm9V17Trf0aKogVmIjdmKfbzFf_2e9AOO4OjQ</recordid><startdate>20240808</startdate><enddate>20240808</enddate><creator>JUNG, Hongryul</creator><creator>YOO, Jihye</creator><creator>LEE, Younho</creator><creator>SHIM, Inseob</creator><creator>KIM, Namdoo</creator><creator>HWANG, Seonah</creator><creator>SON, Jungbeom</creator><creator>DO, Woomi</creator><creator>KIM, Sunghwan</creator><creator>LEE, Hwa</creator><scope>EVB</scope></search><sort><creationdate>20240808</creationdate><title>HETEROARYL DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT</title><author>JUNG, Hongryul ; YOO, Jihye ; LEE, Younho ; SHIM, Inseob ; KIM, Namdoo ; HWANG, Seonah ; SON, Jungbeom ; DO, Woomi ; KIM, Sunghwan ; LEE, Hwa</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2024262815A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2024</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>JUNG, Hongryul</creatorcontrib><creatorcontrib>YOO, Jihye</creatorcontrib><creatorcontrib>LEE, Younho</creatorcontrib><creatorcontrib>SHIM, Inseob</creatorcontrib><creatorcontrib>KIM, Namdoo</creatorcontrib><creatorcontrib>HWANG, Seonah</creatorcontrib><creatorcontrib>SON, Jungbeom</creatorcontrib><creatorcontrib>DO, Woomi</creatorcontrib><creatorcontrib>KIM, Sunghwan</creatorcontrib><creatorcontrib>LEE, Hwa</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>JUNG, Hongryul</au><au>YOO, Jihye</au><au>LEE, Younho</au><au>SHIM, Inseob</au><au>KIM, Namdoo</au><au>HWANG, Seonah</au><au>SON, Jungbeom</au><au>DO, Woomi</au><au>KIM, Sunghwan</au><au>LEE, Hwa</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>HETEROARYL DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT</title><date>2024-08-08</date><risdate>2024</risdate><abstract>The present invention relates to an isoxazolidin-2-yl-substituted heteroaryl derivative and a pharmaceutical composition for cancer prevention or treatment, comprising the compound as an active ingredient. The compound exhibits high inhibitory activity against the wild type or mutants of at least one of ErbB2 and ErbB4 and thus can be useful for treating cancers in which ErbB2 and ErbB4 are expressed.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_epo_espacenet_US2024262815A1 |
source | esp@cenet |
subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | HETEROARYL DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-11T22%3A37%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=JUNG,%20Hongryul&rft.date=2024-08-08&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2024262815A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |